(April 16, 2018, 1:19 PM EDT) -- WASHINGTON, D.C. –— The U.S. Supreme Court on April 16 asked the U.S. solicitor general for his views on whether false claims lawsuits can be brought when the federal government continued to pay for drugs at issue (Gilead Sciences, Inc. v. United States, ex rel. Jeffrey Campie, et al., No. 17-936, U.S. Sup.)....